Pfizer recalls Accuretic blood pressure tablets due to a nitrosamine impurity
Consumer Products
Mar 3rd, 2022 @ 12:00 PM

Basic Details

Category: Health product - Drugs
Issue: Health products - Contamination
Product: Accuretic (quinapril hydrochloride and hydrochlorothiazide)
What to do: Continue taking your medication unless you have been advised to stop by your health care provider. Not treating your condition may pose a greater health risk. Contact your health care provider to discuss other treatment options.
Alert type: Public advisory

Products

DINProductLotExpiry
02237369Accuretic  20/25mgFA92242022-07-31
02237369Accuretic  20/25mgEA07812022-07-31
02237368Accuretic  20/12.5mgET95112022-07-31
02237368Accuretic  20/12.5mgEF30872022-07-31
02237367Accuretic  10/12.5mgEJ51922022-07-31
02237368Accuretic  20/12.5mgEX44112022-07-31
02237367Accuretic 10/12.5mgFM95262023-08-31
02237367Accuretic 10/12.5mgFA37362022-07-31

Recall Monitor

Information presented from Recalls and Safety Alerts dataset, provided by the Government of Canada through the Open Government initiative and is subject to the Open Government License.

You can access this data free of charge via Recall Monitor, or through the Healthy Canadians website.

Get personalized SMS or Email notifications about recall alerts that matter by subscribing to Recall Monitor.

Recall Monitor is not endorsed by, or is an official product of the Government of Canada.

Made with in Vancouver, BC

© Mad Filaments Software Inc.